Latest Cancer Research Stories
Researchers have identified a molecule that blocks the activity of a disease-causing enzyme – a breakthrough that could ultimately lead to the development of a wonder drug that could be used to fight many different diseases.
New genetic links to prostate cancer can identify men at higher risk and may lead to targeted screening, according to researchers at CPIC and colleagues. Fremont,
LAUSANNE, Switzerland, September 26, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs
SAN DIEGO, Sept. 25, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (OTCQB: TELKD), a clinical stage oncology drug development company, announced today that the U.S.
Researchers at the University of Pittsburgh School of Medicine have been selected by the National Institutes of Health to develop a microfluidic, 3D human liver model for drug efficacy and toxicity
LAUSANNE, Switzerland, September 24, 2014 /PRNewswire/ -- Sophia Genetics, the European leader in NGS data analysis, has received the CE-IVD mark for genetic testing of
Attendance Doubled and Over $115,000 Raised to Fight Lung Cancer WASHINGTON, Sept.
CAMBRIDGE, England, September 23, 2014 /PRNewswire/ -- New spin-out from Cancer Research UK launched with funding from Imperial Innovations, Cambridge Innovation
Swim4TheCure’s first event will feature a long-time member of the NFCR Board of Directors, Mark R.
Founding partner Equinox and their instructors led participants on stationary bikes; participants cycled to support rare cancer research at Memorial Sloan Kettering Cancer Center, which owns and operates
- A gift; a largess; a gratuity; a present; a dole.